The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis

[1]  J. Puustinen,et al.  CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation , 2014, Journal of Neuroinflammation.

[2]  C. Lechner,et al.  [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine]. , 2014, Der Nervenarzt.

[3]  C. Lechner,et al.  CXCL13 als Biomarker der akuten Neuroborreliose , 2014, Der Nervenarzt.

[4]  F. Strle,et al.  Diagnostic Value of Cytokines and Chemokines in Lyme Neuroborreliosis , 2013, Clinical and Vaccine Immunology.

[5]  V. Fingerle,et al.  CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings , 2012, BMC Infectious Diseases.

[6]  J. Papp,et al.  Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. , 2012, MMWR. Morbidity and mortality weekly report.

[7]  H. Hefter,et al.  A Case of Relapsing-Remitting Neuroborreliosis? Challenges in the Differential Diagnosis of Recurrent Myelitis , 2012, Case Reports in Neurology.

[8]  C. Klötzsch,et al.  Leitlinien für Diagnostik und Therapie in der Neurologie , 2012 .

[9]  M. Haubitz,et al.  Elevation of serum CXCL13 in SLE as well as in sepsis , 2011, Lupus.

[10]  H. Pfister,et al.  A prospective study on the role of CXCL13 in Lyme neuroborreliosis , 2011, Neurology.

[11]  F. Bakels,et al.  Discriminating Lyme Neuroborreliosis from Other Neuroinflammatory Diseases by Levels of CXCL13 in Cerebrospinal Fluid , 2011, Journal of Clinical Microbiology.

[12]  J. Ernerudh,et al.  Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis. , 2011, The Journal of infection.

[13]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[14]  G Stanek,et al.  Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  C. Marra,et al.  CXCL13 as a Cerebrospinal Fluid Marker for Neurosyphilis in HIV-Infected Patients With Syphilis , 2010, Sexually transmitted diseases.

[16]  H. Pfister,et al.  The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis , 2009, Journal of Neuroinflammation.

[17]  A. Ludolph,et al.  The chemokine CXCL13 in acute neuroborreliosis , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  Lars Fischer,et al.  CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients , 2009, Clinical Cancer Research.

[19]  Meier,et al.  Leitlinien für Diagnostik und Therapie in der Neurologie: Herausgegeben von der Kommission „Leitlinien“ der Deutschen Gesellschaft für Neurologie (DGN) , 2008 .

[20]  H. Pfister,et al.  Borrelia garinii Induces CXCL13 Production in Human Monocytes through Toll-Like Receptor 2 , 2007, Infection and Immunity.

[21]  J. Newcombe,et al.  Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. , 2006, Brain : a journal of neurology.